Immuron (IMRN) Total Current Liabilities (2016 - 2025)
Immuron (IMRN) posted quarterly Total Current Liabilities of $19662.1 for Q3 2025, down 27.15% year-on-year from $26989.8 in Q3 2024, and down 98.58% on a QoQ basis from $1.4 million in Q2 2025.
Immuron (IMRN) Total Current Liabilities (2016 - 2025) Analysis & Trends
Immuron (IMRN) has reported Total Current Liabilities for 10 consecutive years, with $19662.1 the latest figure, recorded in Q3 2025.
- Quarterly Total Current Liabilities fell 27.15% year-over-year to $19662.1 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $19662.1 (down 27.15% YoY) and the FY2025 annual result came in at $19662.1, down 27.15% from the prior year.
- Total Current Liabilities declined to $19662.1 in Q3 2025 per IMRN's latest filing, from $1.4 million in the prior quarter.
- Over the last five years, Total Current Liabilities for IMRN reached as high as $2.2 million in Q2 2023 and fell as low as $15706.0 in Q4 2023.
- A 5-year average of $939665.7 and a median of $1.1 million in 2022 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2021 — Total Current Liabilities jumped 16055.14% — and 2023, when it sank 98.52%.
- Year by year, Total Current Liabilities stood at $792280.3 in 2021, then surged by 33.97% to $1.1 million in 2022, then plunged by 98.52% to $15706.0 in 2023, then surged by 7673.27% to $1.2 million in 2024, then slumped by 98.39% to $19662.1 in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $19662.1, $1.4 million, and $1.2 million for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | 19,662.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 19,662.09 |
| Jun 30, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 9, 2024 | 26,989.79 |
| Jun 30, 2024 | 1.91 Mn |
| Dec 31, 2023 | 15,706.03 |
| Sep 28, 2023 | 1.57 Mn |
| Aug 30, 2023 | 22,191.39 |
| Jun 30, 2023 | 2.22 Mn |
| Dec 31, 2022 | 1.06 Mn |
| Aug 31, 2022 | 1.06 Mn |
| Jun 30, 2022 | 1.06 Mn |
| Dec 31, 2021 | 792,280.27 |
| Jun 30, 2021 | 792,280.27 |
| Dec 31, 2020 | 4,904.20 |
| Sep 1, 2020 | 516,411.00 |
| Jun 30, 2020 | 364,702.19 |
| Dec 31, 2019 | 5,164.11 |
| Jun 30, 2019 | 1.20 Mn |
| Dec 31, 2018 | 803,338.00 |